SPRCSciSparc Ltd. stock chart & analysis
Conviction 36Scan · Fri, Oct 23, 2026SciSparc Ltd. (SPRC) closed at $1.09 (-9.17%) on Oct 23, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 15, RS Rating 1, -97.3% from its 52-week high, -92.2% year to date.
Price chart, 63 bars from Tue, Jul 28, 2026 to Fri, Oct 23, 2026. Last close $1.09, high $11.51, low $1.07.
Why SPRC moved
From the StockSetups movers recaps that covered SPRC, newest first. A recap states what was known that day.
- After hours+74.3%
SciSparc jumped 74.3% after the bell, trading up to $1.90 on 5,697,379 after-hours shares. That is about three times its 20-day average of 1,813,400, though after-hours volume is normally far lighter than the regular session. Market cap is only about $4.9 million.
After-Hours Movers Oct 23, 2026: Why SPRC, MACI, RENT Jumped →
SPRC technical analysis
Trend
SPRC is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 77.0% below the 50-day ($4.75) and 81.9% below the 200-day ($6.02). ADX(14) at 29 points to a strong, established trend. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 15, in oversold territory. MACD crossed below its signal line 9 sessions ago. A bullish RSI divergence is in place. A bullish MACD divergence is in place. Its RS Rating of 1 puts its weighted 12-month performance ahead of about 1% of the US market.
Volume and volatility
Volume on the latest session ran 0.1× its 20-day average. It trades about $3.6M a day on average. ATR(14) is $0.4778, 43.8% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.79) shows distribution.
Key levels
The chart pattern's support is $4.30 and its resistance $5.46. The 52-week range is $1.09 to $40.20; price is 97.3% below the high and 0.0% above the low. The VWAP anchored at the 52-week high is $8.52, above price.
Performance
SPRC returned -35.9% (1 week), -79.8% (1 month), -78.2% (3 months), -83.7% (6 months), -97.1% (1 year), -92.2% (year to date).
About SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Listed 2021 · 3 employees
Recent news
- Three sites, including Yale, await Tourette trial supplies from SciSparc (SPRC)'s subsidiary.Stock Titan · Fri, Oct 23, 2026
- How Far Can New Plans Take SciSparc (NASDAQ:SPRC), J-Star Holding (NASDAQ:YMAT), Astrotech (NASDAQ:ASTC) and House of Doge (NASDAQ:HODO)?Kalkine · Fri, Oct 23, 2026
- SPRC_STAR PETROLEUM REFINING (SPRC.BK) Q2 FY2025 earnings call transcriptYahoo Finance · Thu, Oct 22, 2026
- SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette SyndromeGlobeNewswire · Thu, Oct 22, 2026
- SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance ApplicationsYahoo Finance · Mon, Oct 19, 2026
- AI that can plan and act on its own is one area SciSparc plans to evaluate for cybersecurity and finance.Stock Titan · Mon, Oct 19, 2026
Insider activity
SEC Form 4 transactions in SPRC · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shrem Itschak Director · Ordinary Shares · 2026-06-01 | Sell | 462 | $5K | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in SPRC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.